V. Nezgovorova

Potential of cannabinoids as treatments for autism spectrum disorders.

E. Hollander, O. Devinsky, B. Taylor, 2021, Journal of psychiatric research.

New perspectives in the treatment of body dysmorphic disorder

E. Hollander, K. Hong, V. Nezgovorova, 2018, F1000Research.

Challenges in assessing change in autistic adults: scale limitations and discrepancies in reporting in clinical trials

E. Hollander, B. Taylor, E. Racine, 2021, International journal of psychiatry in clinical practice.

Modulating neuroinflammation in COVID-19 patients with obsessive-compulsive disorder

E. Hollander, S. Pallanti, C. Ferretti, 2021, Journal of Psychiatric Research.

Pharmacotherapy in body dysmorphic disorder: relapse prevention and novel treatments

E. Hollander, K. Hong, V. Nezgovorova, 2019, Expert opinion on pharmacotherapy.

Pharmacological Treatment of Body Dysmorphic Disorder

E. Hollander, G. Uzunova, K. Hong, 2019, Current neuropharmacology.

Commentary on the article: "Maintenance of wellness in patients with obsessive-compulsive disorder who discontinue medication after exposure/response prevention augmentation A randomized clinical trial" Foa EB et al., JAMA Psychiatry. 2022;79(3):193-200 (1).

E. Hollander, N. Fineberg, J. Grant, 2022, Comprehensive Psychiatry.

Optimizing first line treatments for adults with OCD.

N. Fineberg, E. Hollander, V. Nezgovorova, 2022, Comprehensive psychiatry.